Today our lab is excited to share a new study in Cell: “Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound.”
We engineered a compact CRISPR system that can be activated at specific locations in the body using focused ultrasound (🧵)
@AntonAAAutzen@ScienceTM Thanks Anton! Still clearly recall running experiments on my original projects with you in the week before lockdown. That story will come...
Pleased to report, at long last, the publication of ML2006a4, our SARS-CoV-2 protease inhibitor for COVID-19, in @ScienceTM.
Compared to nirmatrelvir, the inhibitor in Paxlovid, ML2006a4 binds more tightly and has greater antiviral activity in vivo.
https://t.co/022STQTyz8
@michaelzlin Finally, a big thanks to @novonordiskfond and @StanfordBioX for supporting my time at @Stanford from 2018 to 2022. While this was a pivot from my original line of research - this project surely captures the interdisciplinary and collaborative spirit of the program.
Pleased to report, at long last, the publication of ML2006a4, our SARS-CoV-2 protease inhibitor for COVID-19, in @ScienceTM.
Compared to nirmatrelvir, the inhibitor in Paxlovid, ML2006a4 binds more tightly and has greater antiviral activity in vivo.
https://t.co/022STQTyz8
Pleased to report, at long last, the publication of ML2006a4, our SARS-CoV-2 protease inhibitor for COVID-19, in @ScienceTM.
Compared to nirmatrelvir, the inhibitor in Paxlovid, ML2006a4 binds more tightly and has greater antiviral activity in vivo.
https://t.co/022STQTyz8
As I hope is clear, the world (not to mention Pfizer) was darn lucky that BPV existed.
And BPV was no sure thing; it also took much tweaking to become an oral drug. For that, we can thank Kenyan chemist F. G. Njoroge, who led its development at Schering
https://t.co/bLA9bKUB4J
Our first paper is out in @CellCellPress! Led by @born2raisecell, we present a programmable reaction-diffusion system that generates synthetic protein waves, oscillations, and patterns for spatiotemporal circuit design and FM data-encoding in human cells. https://t.co/lNRtRdJAxx
Congratulations to the recipients of a DDF Sapere Aude Research Leader grant from @DFF_raad 🎉 While I await feedback on why I wasn't selected for the program, my interview raised some concerns for me and I believe it's crucial to share my experience. 🧵#dkforsk
RFdiffusionAA generating a small molecule binding protein against an experimental FXIa inhibitor (OQO), a ligand which is significantly different than any in its training dataset.
Very excited to share RoseTTAFold All-Atom and RFdiffusion All-Atom, methods for structure prediction and design of biomolecular assemblies! https://t.co/iG6rD0LHsi 1/n
In this week’s @nature WorldView column, I write:
“The EU can and should play a greater part in ensuring global food security. I urge both ministers and legislators to…resist calls to further limit this technology.” #NGT#CRISPR
https://t.co/MbTm1CfH4J
Excited to share our research in @nchembio ! We developed a bacterial orthogonal DNA replication system (BacORep) and equiped it with an engineered error-prone orthogonal DNA polymerase. OrthoRep, you just got a new friend :) 👉 https://t.co/mkVC3dqDsZ